157 related articles for article (PubMed ID: 18037591)
1. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.
Park JY; Zheng W; Kim D; Cheng JQ; Kumar N; Ahmad N; Pow-Sang J
Cancer Detect Prev; 2007; 31(5):359-65. PubMed ID: 18037591
[TBL] [Abstract][Full Text] [Related]
2. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer.
Park JY; Helm JF; Zheng W; Ly QP; Hodul PJ; Centeno BA; Malafa MP
Pancreas; 2008 May; 36(4):e32-9. PubMed ID: 18437076
[TBL] [Abstract][Full Text] [Related]
3. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer.
Park JY; Kim D; Yang M; Park HY; Lee SH; Rincon M; Kreahling J; Plass C; Smiraglia DJ; Tockman MS; Kim SJ
Lung Cancer; 2013 Mar; 79(3):198-204. PubMed ID: 23273563
[TBL] [Abstract][Full Text] [Related]
4. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.
Ueno M; Toyota M; Akino K; Suzuki H; Kusano M; Satoh A; Mita H; Sasaki Y; Nojima M; Yanagihara K; Hinoda Y; Tokino T; Imai K
Tumour Biol; 2004; 25(3):134-40. PubMed ID: 15361710
[TBL] [Abstract][Full Text] [Related]
6. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
[TBL] [Abstract][Full Text] [Related]
7. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
Li H; Myeroff L; Smiraglia D; Romero MF; Pretlow TP; Kasturi L; Lutterbaugh J; Rerko RM; Casey G; Issa JP; Willis J; Willson JK; Plass C; Markowitz SD
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8412-7. PubMed ID: 12829793
[TBL] [Abstract][Full Text] [Related]
8. Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.
Vinarskaja A; Schulz WA; Ingenwerth M; Hader C; Arsov C
Urol Oncol; 2013 Jul; 31(5):622-7. PubMed ID: 21803613
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
[TBL] [Abstract][Full Text] [Related]
10. Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
Hernández-Juárez J; Vargas-Sierra O; Herrera LA; Cantú De León D; Fernández-Retana J; Pérez-Plasencia C; López-Camarillo C; Gariglio P; Díaz-Chávez J
Int J Oncol; 2019 May; 54(5):1613-1624. PubMed ID: 30896789
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the human SLC5A8 gene promoter.
Zhang Y; Bao YL; Wu Y; Yu CL; Sun Y; Li YX
Cancer Genet Cytogenet; 2010 Jan; 196(2):124-32. PubMed ID: 20082847
[TBL] [Abstract][Full Text] [Related]
12. Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas.
Porra V; Ferraro-Peyret C; Durand C; Selmi-Ruby S; Giroud H; Berger-Dutrieux N; Decaussin M; Peix JL; Bournaud C; Orgiazzi J; Borson-Chazot F; Dante R; Rousset B
J Clin Endocrinol Metab; 2005 May; 90(5):3028-35. PubMed ID: 15687339
[TBL] [Abstract][Full Text] [Related]
13. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
14. Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.
Lin HY; Park HY; Radlein S; Mahajan NP; Sellers TA; Zachariah B; Pow-Sang J; Coppola D; Ganapathy V; Park JY
Urology; 2011 Oct; 78(4):971.e1-9. PubMed ID: 21802122
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors.
Pulukuri SM; Patibandla S; Patel J; Estes N; Rao JS
Oncogene; 2007 Aug; 26(36):5229-37. PubMed ID: 17325663
[TBL] [Abstract][Full Text] [Related]
18. SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases.
Thangaraju M; Gopal E; Martin PM; Ananth S; Smith SB; Prasad PD; Sterneck E; Ganapathy V
Cancer Res; 2006 Dec; 66(24):11560-4. PubMed ID: 17178845
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
20. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells.
Zhang Y; Bao YL; Yang MT; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
Int J Biochem Cell Biol; 2010 Dec; 42(12):1964-72. PubMed ID: 20732443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
